Eli Lilly and Company announced data demonstrating more patients with moderately to severely active Crohn's disease treated with mirikizumab achieved histologic response at Week 52 compared to ...

HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:30 Hrs [IST] HealthPlix Tech ...

C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:15 Hrs [IST] Th ...

Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

MedGenome marks 10 years of genomics in India, works to further its research and diagnostics in disease prevention: Our Bureau, Bengaluru Tuesday, October 15, 2024, 16:40 Hrs [IST ...

Lundbeck to buy clinical-stage biopharma company, Longboard Pharmaceuticals for USD 2.6 billion: Valby, Denmark Tuesday, October 15, 2024, 15:00 Hrs [IST] H. Lundbeck A/S (Lundbec ...

Ampath collaborates with Innocent Hearts Hospital to expand diagnostic services in Jalandhar: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:50 Hrs [IST] American Institute o ...

Our Bureau, Bengaluru Tuesday, October 15, 2024, 11:00 Hrs [IST] ...

GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps: London, UK Tuesday, October 15, 2024, 10:00 Hrs [IST] GSK ...

Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...